SCHEMBL14282872

SCHEMBL14282872

CCCCCCCCCC(=O)CC(=O)Nc1cc(Cl)ccc1O

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 3/20 0.61
▸ MEN1 O00255 6/20 0.59
▸ KMT2A Q03164 6/20 0.59
▸ HPGD P15428 1/20 0.59
▸ ALOX15 P16050 1/20 0.52
▸ MAPK1 P28482 1/20 0.52
▸ KDM4E B2RXH2 1/20 0.52
▸ ALDH1A1 P00352 1/20 0.52
▸ GAA P10253 2/20 0.50
▸ NPC1 O15118 1/20 0.50
▸ RAB9A P51151 1/20 0.50
▸ L3MBTL1 Q9Y468 1/20 0.49
▸ EP300 Q09472 1/20 0.49
▸ LMNA P02545 1/20 0.47
▸ KCNMA1 Q12791 2/20 0.47
▸ EPHX2 P34913 1/20 0.46
▸ STAT3 P40763 1/20 0.46
▸ CYP1A2 P05177 1/20 0.45
▸ CYP3A4 P08684 1/20 0.45
▸ CYP2C19 P33261 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23281438 0.85 GAA (0.60) POLBMEN1KMT2AMAPK1GAA
SCHEMBL29721853 0.82 POLB (0.72) POLBMEN1KMT2AHPGDALOX15
SCHEMBL28734394 0.82 POLB (0.72) POLBMEN1KMT2AHPGDALOX15
SCHEMBL12083396 0.81 EP300 (0.57) MEN1KMT2AALDH1A1EP300
SCHEMBL5144511 0.80 POLB (0.86) POLBMEN1KMT2AHPGDALOX15
SCHEMBL31661769 0.79 POLB (0.69) POLBMEN1KMT2AHPGDALOX15
SCHEMBL7718043 0.79 POLB (0.69) POLBMEN1KMT2AHPGDALOX15
SCHEMBL3046406 0.79 POLB (0.69) POLBMEN1KMT2AHPGDALOX15
SCHEMBL7717051 0.79 POLB (0.69) POLBMEN1KMT2AHPGDALOX15
SCHEMBL5656576 0.79 POLB (0.69) POLBMEN1KMT2AHPGDALOX15

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20220411397-A1 ANALOGUES OF N-ACYL-HOMOSERINE LACTONES AND PHARMACEUTICAL COMPOSITION COMPRISING SAME ECOLE NORMALE SUPERIEURE (FR) 2022-12-29 — — US disclosed
US-20220411397-A1 ANALOGUES OF N-ACYL-HOMOSERINE LACTONES AND PHARMACEUTICAL COMPOSITION COMPRISING SAME ECOLE NORMALE SUPERIEURE (FR) 2022-12-29 — — US disclosed
CN-115209891-A Analogs of N-acyl-homoserine lactones and pharmaceutical compositions containing the same 索邦大学 2022-10-18 — — CN disclosed
EP-4048258-A1 ANALOGUES OF N-ACYL-HOMOSERINE LACTONES AND PHARMACEUTICAL COMPOSITION COMPRISING SAME SORBONNE UNIVERSITE (FR) 2022-08-31 — — EP disclosed
WO-2021078952-A1 ANALOGUES OF N-ACYL-HOMOSERINE LACTONES AND PHARMACEUTICAL COMPOSITION COMPRISING SAME SORBONNE UNIVERSITE (FR) 2021-04-29 — — WO disclosed
US-20080027115-A1 COMBINATORIAL LIBRARIES OF AUTOINDUCER ANALOGS, AUTOINDUCER AGONISTS AND ANTAGONISTS, AND METHODS OF USE THEREOF THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (US) 2008-01-31 — — US disclosed
US-20080027115-A1 COMBINATORIAL LIBRARIES OF AUTOINDUCER ANALOGS, AUTOINDUCER AGONISTS AND ANTAGONISTS, AND METHODS OF USE THEREOF THE RESEARCH FOUNDATION OF STATE UNIVERSITY OF NEW YORK (US) 2008-01-31 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080027115-A1 COMBINATORIAL LIBRARIES OF AUTOINDUCER ANALOGS, AUTOINDUCER AGONISTS AND ANTAGONISTS, AND METHODS OF USE THEREOF QRFPR, CASR, BLVRB POLB 4596/4885MEN1 3649/4885KMT2A 3882/4885
US-20220411397-A1 ANALOGUES OF N-ACYL-HOMOSERINE LACTONES AND PHARMACEUTICAL COMPOSITION COMPRISING SAME AHCYL1, LTC4S, AHCY POLB 4848/4885MEN1 1049/4885KMT2A 3751/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback